Medical Laboratories & Research

  1.  Whether combating river blindness in Zambia or treating arthritis in Canada, Merck continues to prove its worth in the marketplace and among demanding investors.

    How Merck Found Its Way Into Millions Of Medicine ...

    With over $40 billion in revenue from pharmaceutical sales, there's a good chance ...
  2. Both pharma and biotech stocks are faced with a costly process that, when successful, can produce extremely profitable products.

    Pharmaceutical Vs. Biotech Investing: Is It Worth ...

    Investopedia explains: Both pharma and biotech stocks are faced with a costly process ...
  1. Interested In Healthcare Stocks? Look At This ...

    Healthcare companies seem to be poised to make a move higher over the months ahead. ...
  2. Agilent Grinding Through Challenging Market Conditions

    Agilent may be quite a bit stronger than its reported numbers would indicate.
  3. Pricing Still A Long-Term Risk, But Illumina ...

    Pricing Still A Long-Term Risk, But Illumina Continues To Build A Sequencing Fortress ...
  4. Agilent Isn't Making It Easy On Investors

    Core operating performance at Agilent needs to improve
Trading Center